Ildong to join hands with Taiwan Liposome Company

Published: 2010-12-06 06:56:00
Updated: 2010-12-06 06:56:00
Ildong Pharmaceutical plans to commercialize ProFlow Injection (prostaglandin E1) in Korea through an exclusive distribution with Taiwan based Taiwan Liposome Company (TLC).

Ildong forecasts that TLC’s ProFlow will take 30 percent of the domestic PGE1 Injection market valued at 15 billion won....

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.